Finadyne Solution 50ml

herapy in the treatment of swine respiratory diseases. Contraindications Do not exceed the stated dose or the duration of treatment. Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is hypersensitivity to the product. Do not use the product within 48 hours before expected parturition in cows. Do not administer to pregnant mares. Do not administer to pregnant sows, gilts at mating and in breeding boars. Special warning for each target species Non steroidal, anti-inflammatory drugs are not permitted under the rules of Racing and under rules covering other competition events. The Royal College of Veterinary Surgeons has given advice to the Veterinary Profession regarding the use of anti-inflammatory drugs in competing horses. It states that “if a veterinarian recommends the discontinuation of any such drug not less than eight days before racing, he should feel sure that he has catered for all but the most exceptional case”. Do not exceed the recommended dose or duration of treatment. Special precautions for use Avoid intra-arterial injection. NSAIDS are known to have the potential to delay parturition through a tocolytic effect by inhibiting prostaglandins that are important in signalling the initiation of parturition. The use of the product in the immediate post-partum period may interfere with uterine involution and expulsion of foetal membranes resulting in retained placentae. See also section “Use during pregnancy”. Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. Do not use in hypovolaemic animals except in the case of endotoxaemia or septic shock. It is preferable that NSAIDs which inhibit prostaglandin synthesis are not administered to animals undergoing general anaesthesia until fully recovered. The cause of colic should be determined and treated with concurrent therapy. The product should not be used in piglets weighing less than 6kg. Operator warnings Avoid contact with skin or eyes. In case of skin contact, wash exposed area with water. In case of eye contact, wash eyes thoroughly with clean water and seek medical advice. Take care against accidental self injection. Wash hands after use. Adverse reactions Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID). Untoward effects include gastro-intestinal irritation, ulceration and, in dehydrated or hypovolaemic animals, potential for renal damage. In pigs transient irritation may occur at the injection site, this resolves spontaneously within 14 days. Use during pregnancy or lactation The product may be used in pregnant and lactating cattle. The product should only be administered within the first 36 hours post-partum following a benefit/risk assessment performed by the responsible veterinarian and treated animals should be monitored for retained placentae. Do not use in pregnant mares or pregnant sows. Safety studies in pregnant mares and pregnant sows have not been conducted. Interaction Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects. Concurrent administration of potentially nephrotoxic drugs should be avoided.